Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 14, 2016 3:04 PM ET

Health Care Technology

Company Overview of HealthPrize Technologies LLC

Company Overview

HealthPrize Technologies LLC provides medication adherence solutions for patients. It offers HealthPrize Engagement Engine, a medication adherence platform and software solution that gathers daily compliance data from users, verifies their prescription refills, and rewards them for adherence. The company collects daily self-reporting through response to text or email messages, online via the HealthPrize dashboard, or via the HealthPrize mobile platform. Its solution combines financial incentives in loyalty points, weekly sweepstakes, and monthly competitions; and education, reminders, and fun. HealthPrize Technologies LLC has a strategic collaboration with MeadWestvaco. The company was found...

50 Water Street

Norwalk, CT 06854

United States

Founded in 2009

Phone:

203-957-3401

Key Executives for HealthPrize Technologies LLC

Co-Founder, Chief Executive Officer and Director
Co-Founder, Chief Medical Officer and Director
Co-Founder and Advisor
Chief Product and Brand Officer
Head of Pharmaceuticals Division and Director
Compensation as of Fiscal Year 2015.

HealthPrize Technologies LLC Key Developments

HealthPrize Technologies Announces EHR Partnership with Aprima Medical Software Inc. to Drive Patient Acquisition, Engagement and Medication Adherence

HealthPrize Technologies and Aprima Medical Software announced a strategic partnership to integrate HealthPrize's proven engagement and adherence solutions into Aprima's innovative Patient Portal. The collaboration will incorporate education, gamification and rewards into the patient EHR experience in an effort to motivate patients toward increased medication adherence and positive behavior change. With the HealthPrize SaaS platform embedded into the Aprima EHR, patients will have direct access through their Patient Portal to an engaging and effective program designed to educate, promote adherence, and add a fun factor through the use of gamification and rewards. Patients enrolled in HealthPrize programs demonstrate persistently high engagement rates and materially higher prescription fill rates as measured by mean number of fills per patient, nearly 50% higher than supporting brands' baselines, on average. Embedding the HealthPrize platform into the Aprima EHR system will bring this proven success to the thousands of primary care and specialty physicians who utilize it. Development of the HealthPrize Aprima interface is expected to begin in the fourth quarter of 2015, with full provider access anticipated by early 2016.

West Pharmaceutical Services, Inc. Announces Medication Adherence Collaboration with Healthprize Technologies

West Pharmaceutical Services, Inc., and HealthPrize Technologies, LLC have collaborated to integrate HealthPrize's software-as-a-service, or SaaS, medication adherence and patient-engagement platform with West's injectable drug delivery systems to provide a connected health solution for pharmaceutical companies. The combined offering will provide voluntary, electronically connected drug delivery systems that track when patients take their medication. The HealthPrize system engages and educates patients to increase adherence and medical literacy, rewarding interaction and compliance with prescribed treatment plans, and contributing to better health outcomes. Phase I of the platform allows for patient self-reporting once the medication has been injected. Phase II simplifies the self-reporting process through bar coding or QR coding of self-injection systems, which, when scanned, reports use of the injection system to the HealthPrize patient-engagement system via a secure cloud environment. Bar coding allows for the recording of other medication details, including manufacturing information, pedigree, expiration date, dosage and more. The final phases of development that are currently in progress are fully integrated injection systems with onboard monitoring and built-in wireless communication capability (integrated connected health) and the connection of legacy, mechanical injectors to the HealthPrize platform via an adaptive attachment (legacy connected health). In all four phases, data captured over time will afford pharmaceutical companies insight into valuable trends and analytics regarding the actual use of their products. The HealthPrize platform leverages a combination of gamification, behavioral economic concepts, education and rewards to maximize motivational impact. Patients enrolled in HealthPrize programs demonstrate persistently high engagement rates and materially higher adherence rates, nearly 50% higher than baseline, on average.

West Pharmaceutical Services, Inc. and HealthPrize Technologies Announce Self-Reporting and Barcoding Capabilities for Self-Injection Technology

West Pharmaceutical Services, Inc. and HealthPrize Technologies, LLC announce the completion of the first two phases of their four-phase strategic collaboration. The companies are working to integrate HealthPrize's Software-as-a-Service (SaaS) medication adherence and patient-engagement platform with West's injectable drug delivery systems to provide an end-to-end connected health solution for pharmaceutical companies and the patients they serve. The combined offering will provide voluntary, electronically connected drug delivery systems that track when patients take their medication. The HealthPrize system engages and educates patients to increase adherence and medical literacy, rewarding interaction and compliance with prescribed treatment plans, and contributing to better health outcomes. Phase 1 of the platform allows for patient self-reporting once the medication has been injected. Phase 2 simplifies the self-reporting process through bar coding or QR coding of self-injection systems, which, when scanned, reports use of the injection system to the HealthPrize patient-engagement system via a secure cloud environment. Bar coding allows for the recording of other medication details, including manufacturing information, pedigree, expiration date, dosage and more. The final phases of development that are currently in progress are fully integrated injection systems with onboard monitoring and built-in wireless communication capability (integrated connected health) and the connection of legacy, mechanical injectors to the HealthPrize platform via an adaptive attachment (legacy connected health). In all four phases, data captured over time will afford pharmaceutical companies insight into valuable trends and analytics regarding the actual use of their products.

Similar Private Companies By Industry

Company Name Region
The Ansar Group, Inc. United States
DrScribe, Inc. United States
Dinmar (Us) Inc. United States
Genesis Digital Imaging, Inc. United States
RedBrick Health Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact HealthPrize Technologies LLC, please visit www.healthprize.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.